60 Degrees Pharmaceuticals, Inc. entered into separate Securities Purchase Agreements with purchasers under Regulation D Section 4(a)(2) to sell unregistered securities, with the closing date in July 2026.
60 Degrees Pharmaceuticals, Inc. entered into separate Securities Purchase Agreements with purchasers under Regulation D Section 4(a)(2) to sell unregistered securities, with the closing date in July 2026.